IRD
Opus Genetics, Inc.
5.10$
+6.1%
vs. previous close
Closing price · As of: Sep 28, 2026
Statements
Cash Flow
Opus Genetics, Inc. (IRD) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -35 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| -3.6 | -6.8 | -19 | 14 | -1.1 | -26 | -35 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | |
| 0.3 | 1.5 | 1.9 | 1.8 | 3.5 | 3.4 | 3.4 | |
| 0.4 | 1.1 | 0.2 | -5.6 | 4.1 | 3.1 | -2.2 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| 0.0 | 0.5 | -0.1 | – | – | 1.2 | – | |
| – | – | – | – | 0.0 | -0.1 | -0.2 | |
| – | – | 0.5 | -0.5 | 0.0 | – | – | |
| 4.7 | 21 | 28 | 3.8 | 9.0 | 4.2 | 50 | |
| 1.1 | 15 | 8.1 | 18 | 7.9 | -20 | 15 | |
| -3.6 | -6.8 | -19 | 14 | -1.1 | -26 | -35 |
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.